ctrl K

Price Alert

Gain Therapeutics Inc. (GANX)

NASDAQ: GANX · Real-Time Price · USD

1.69

-0.08 (-4.52%)

At close: Aug 19, 2025, 3:59 PM

1.69

0.00%

After-hours: Aug 19, 2025, 04:10 PM EDT

Gain Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	10.39M	11.79M	7.31M	36.88M
Short-Term Investments	n/a	5M	12.83M	n/a
Long-Term Investments	31.7K	n/a	1.94M	31.28K
Other Long-Term Assets	32.11K	51.91K	48.32K	53.39K
Receivables	765.76K	242.58K	103.88K	195.45K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	369.89K	n/a	640.31K	n/a
Total Current Assets	11.6M	17.78M	21.09M	37.72M
Property-Plant & Equipment	323.33K	585.18K	804.31K	1.01M
Goodwill & Intangibles	134.27K	193.38K	213.97K	202.61K
Total Long-Term Assets	521.41K	830.46K	3.01M	1.26M
Total Assets	12.12M	18.61M	24.1M	38.99M
Account Payables	946.26K	1.32M	1.63M	560.48K
Deferred Revenue	252.21K	1.12M	55.18K	266.5K
Short-Term Debt	110.18K	118.8K	108.14K	103.83K
Other Current Liabilities	18.49K	1.38M	364.11K	380.00
Total Current Liabilities	3.91M	4.95M	4.13M	2.55M
Long-Term Debt	328.33K	449.05K	495.26K	590.47K
Other Long-Term Liabilities	443.62K	307.45K	157.58K	329.46K
Total Long-Term Liabilities	872.99K	1.08M	1.09M	1.61M
Total Liabilities	4.78M	6.03M	5.22M	4.17M
Total Debt	653.01K	1.03M	1.27M	1.61M
Common Stock	2.71K	1.62K	1.19K	1.19K
Retained Earnings	-81.19M	-60.78M	-38.52M	-20.93M
Comprehensive Income	-247.55K	247.24K	35.63K	-90.64K
Shareholders Equity	7.34M	12.58M	18.88M	34.82M
Total Investments	31.7K	5M	14.77M	31.28K